Mathew S. Kalarickal

Showing 1-1 of 1 articles

Coronary interventions

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

Seth A, Onuma Y, Costa R, Chandra P, Bahl V, Manjunath C, Mahajan A, Ajit Kumar V, Goel PK, Wander G, Kalarickal M, Kaul U

July 20, 2017 | 10.4244/EIJ-D-17-00306

1

Latest news

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

Ahead of print: EAPCI Core Curriculum for PCI (2020)

IVUS guidance during left main PCI: not if, but when and how

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

Left main PCI: are we giving the kiss the attention it deserves?

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke